Fidelity Investments
SCLN

Fidelity Investments’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Fidelity Investments’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,003
Closed -$112K – 2766
2017
Q3 		$112K Hold
10,003
– – ﹤0.01% 2579
2017
Q2 		$110K Hold
10,003
– – ﹤0.01% 2601
2017
Q1 		$98K Buy
+10,003
New +$99.9K ﹤0.01% 2632

Fidelity Investments's SCLN Position: Q4 2017 in Review

Fidelity Investments sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 10,003 shares — an estimated $112K sold.

Fidelity Investments first reported a position in SCLN in Q1 2017 and held it in 3 quarters. The position peaked at $112K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Fidelity Investments reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Fidelity Investments sold 10,003 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $112K.
  • Fidelity Investments first reported a position in Sciclone Pharmaceuticals Inc in Q1 2017 and held it in 3 quarters.
  • Fidelity Investments's Sciclone Pharmaceuticals Inc position peaked at $112K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Fidelity Investments's 13F filing for Q4 2017, filed 12 Feb 2018.